ArticleFrontiers in immunology2026

Phase Ia study to evaluate RO7497987, a FLT3L-fragment Fc fusion protein, in healthy volunteers.

Anthony J Iacovelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.